Qiming Venture Partners Leads $42M New Round In Chinese Biotech Start-Up

This Data Is Locked!

This area is available only to Subscribers.

Abbisko Therapeutics, a Chinese biotech start-up that develops drugs for cancer treatment, announced on Friday that it has raised US$42 million in a new round... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?